Lifeward Regains Nasdaq Compliance After Reverse Stock Split

Medical device manufacturer Lifeward avoids delisting by boosting share price above $1 minimum.

Mar. 11, 2026 at 6:33pm

Got story updates? Submit your updates here. ›

Lifeward, a medical device manufacturer based in Marlborough, Massachusetts, has regained compliance with Nasdaq listing requirements after implementing a 1-for-12 reverse stock split. The company's stock price rose above the $1 minimum requirement, allowing it to avoid delisting from the exchange.

Why it matters

Maintaining Nasdaq listing is crucial for Lifeward, as it provides access to capital markets and enhances the company's credibility. The reverse stock split was a strategic move to boost the share price and meet Nasdaq's minimum requirements, ensuring the company can continue trading on the exchange.

The details

Lifeward received a deficiency letter from Nasdaq in August 2025 for failing to meet the $1 minimum stock price requirement for 30 consecutive business days. The company was given until February 2026 to regain compliance, but after failing to do so, was granted a 180-day extension. Lifeward then announced a 1-for-12 reverse stock split, which consolidated every 12 shares into one, effectively increasing the share price. As a result, Lifeward's stock price rose above the $1 minimum, allowing the company to regain Nasdaq compliance.

  • On August 5, 2025, Lifeward received a deficiency letter from Nasdaq for failing to meet the $1 minimum stock price requirement.
  • Lifeward was initially given until February 2, 2026, to regain compliance, but was later granted a 180-day extension.
  • On March 2, 2026, Lifeward announced a 1-for-12 reverse stock split to boost its share price.
  • On February 24, 2026, Lifeward maintained the required minimum $1 per share stock price for 10 consecutive business days.

The players

Lifeward

A medical device manufacturer based in Marlborough, Massachusetts, that was at risk of being delisted from the Nasdaq exchange due to its low stock price.

Nasdaq

The stock exchange that requires companies to maintain a minimum $1 per share stock price to remain listed.

Oramed Pharmaceuticals

A New York City-based company that Lifeward plans to sell up to 49.99% of its firm to in exchange for Oramed's oral protein delivery technology.

Almog Adar

The Chief Financial Officer of Lifeward, who expressed the company's commitment to regaining Nasdaq compliance.

Got photos? Submit your photos here. ›

What they’re saying

“The company is working very hard to be in compliance again and to achieve the dollar threshold. We believe that in the next…180 days, the company will achieve the dollar target and will be in compliance again with the Nasdaq.”

— Almog Adar, Chief Financial Officer

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

Maintaining a Nasdaq listing is crucial for Lifeward, as it provides access to capital markets and enhances the company's credibility. The reverse stock split was a strategic move to boost the share price and meet Nasdaq's minimum requirements, ensuring the company can continue trading on the exchange.